Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
about
Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS responseRepression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene productActivation of interleukin-6 gene expression through the NF-kappa B transcription factorVascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter.A synthetic analog of the 3-deoxy-D-manno-2-octulosonic acid disaccharide moiety of rough-type endotoxins does not bind to mouse peritoneal macrophages and human monocytesActivation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists.Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6.High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like protein.Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models.Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.Amniotic fluid interleukin 6 in preterm labor. Association with infection.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry.Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThe role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.Interleukin-6 production in posttransplant lymphoproliferative disease.Interleukin-6 immunoreactivity in human tumorsDevelopment of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein BRegulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndromeA role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells.Antitumor activity of recombinant interleukin 6 in miceExpression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicityInterleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cellsRegulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblastsInfection of human endothelial cells with Epstein-Barr virus.Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signalingInterleukin-6 in peripheral blood and inflammatory sites in Behçet's disease.A reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy). How 'Inflammatory' Cytokines may have A therapeutic Role.Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesisMacrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids.Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens.Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populationsInterleukin-6 signals activating junB and TIS11 gene transcription in a B-cell hybridoma.Long-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measuresThe role of lactic acid in autocrine B-cell growth stimulation
P2860
Q28213451-7531EC4C-799E-4160-8D6E-0DA9D2637A4CQ28645822-CF33AB96-5F87-43D3-9D3C-18F750E59D8BQ28646310-7B1301C7-4637-422B-9326-283AD8CF1434Q30319434-25DAB563-3FAF-4715-A3B4-B4C944AD7349Q33562993-A201C0B0-048C-49D4-8180-F02608F2A802Q33607039-F0CDA780-79B2-4B7A-9DD3-1FF34BEAE71EQ33647124-426A9B3F-5929-4D49-B041-0254DBFFB30EQ33661906-2A5E0F30-961C-4476-B384-482CCB58FEF5Q33671836-3027DF38-6B43-49CD-8CD9-0A7ADD6B5D7FQ33684419-C6D9CD0B-F5B2-4C20-BD82-7CFE3BC0A4E3Q33844249-C618FF2B-832B-489A-84D8-D4147F19EEE7Q34203756-415CB5D8-C7B4-4215-9965-F70B9BEA41E6Q34225642-ACFED901-2E6D-4743-9F7B-89A330C4936AQ34249986-1FB8D062-2086-4711-A76B-3F4329A11058Q34302121-E3FD0B8A-0AA2-4E10-A9EE-A0C39971EFC0Q34379763-85F77258-E72F-47B6-8998-E47E7446A270Q34636851-E1965998-A577-4117-90FC-B29BB7DE23C6Q35092953-101A296E-8396-4BE0-B545-E7E4B699FAA9Q35550033-7B5E0AC3-B51C-4FF6-88B6-E687E6A53F06Q35611724-C5DED21E-B78F-43C3-A1F0-F18A2F331CC1Q35816757-D7F48E34-0FA6-4D70-8E57-02D9FE82B400Q35830557-404F2B87-E8B9-4868-B420-6ED2DE058C55Q35840812-BD38A342-B9D5-4F02-9234-B9BB68BA9723Q36015363-6DF2973B-AA40-4BA3-81DA-7DBCCB23BF35Q36350671-DD515F42-9C0B-4710-8B49-77A761EFF7BCQ36351981-9B81CC73-7A83-4EFA-98DF-11E47DFD0254Q36357033-D4F57F78-A00D-4F52-9FA8-89AAD9A4D37BQ36357674-D5D13A7D-FDCD-4592-8673-7B32B793722DQ36365385-EF73794B-8A73-424D-8C8F-C98F02889ED4Q36368369-9E0E62D7-A307-492E-BF68-636AB47B6079Q36626997-BA3F5CEA-5C97-4FD5-BB1F-3E7F107BA41DQ36627620-450039D3-1A2B-4EA4-8ACE-9FE20CF93A13Q36808389-BF0B06BD-C3C9-40D3-8B1B-A8E27CF18BA1Q36882284-2A5CDD4F-EB29-4FB9-9075-BB97A17AB501Q36950501-94CD2001-9802-431B-948F-7A7EC5CDF993Q36954959-12AA1169-029D-4330-AAC0-3C3A80D5AE9BQ36955399-423C5EDF-F8EA-414A-A842-5A5BE0D131B4Q36958795-3E59CE4E-8617-477A-B4BF-E9C276912BA9Q37019144-654085B4-BE55-4541-A126-C09A0C8FBDFFQ37640575-7C07341F-305C-4E72-9585-68B49970B79A
P2860
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
description
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 1988
@ast
scientific journal article
@en
vedecký článok (publikovaný 1988/01/29)
@sk
vědecký článek publikovaný v roce 1988
@cs
wetenschappelijk artikel (gepubliceerd op 1988/01/29)
@nl
наукова стаття, опублікована в січні 1988
@uk
научни чланак (објављен 1988/01/29)
@sr
name
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@ast
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@en
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@nl
type
label
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@ast
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@en
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@nl
prefLabel
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@ast
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@en
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@nl
P2093
P3181
P356
P1433
P1476
Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)
@en
P2093
G. C. Washington
K. B. Seamon
K. D. Jones
N. D. Goldman
P. B. Sehgal
S. E. Pike
P304
P3181
P356
10.1126/SCIENCE.2829354
P407
P577
1988-01-29T00:00:00Z